Ionis Pharmaceuticals Q3 Adj. EPS $(0.40) Beats $(1.21) Estimate, Sales $243.000M Beat $182.117M Estimate
Benzinga Newsdesk 7 hours ago
NewsEarningsEarnings Beats
Ionis Pharmaceuticals (NASDAQ:IONS) reported quarterly losses of $(0.40) per share which beat the analyst consensus estimate of $(1.21) by 66.94 percent. This is a 34.43 percent increase over losses of $(0.61) per share
Ionis Pharmaceuticals (NASDAQ:IONS) reported quarterly losses of $(0.40) per share which beat the analyst consensus estimate of $(1.21) by 66.94 percent. This is a 34.43 percent increase over losses of $(0.61) per share from the same period last year. The company reported quarterly sales of $243.000 million which beat the analyst consensus estimate of $182.117 million by 33.43 percent. This is a 54.78 percent increase over sales of $157.000 million the same period last year.